Adrenal insufficiency in the critically III: A new look at an old problem

Chest

Volumn 122, Issue 5, 2002, Pages 1784-1796

  Marik, Paul E ^a   Zaloga, Gary P ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adrenal axis; Adrenal corticotropin hormone; Adrenal insufficiency; Cortisol; Critical care; Glucocorticoid receptors; Hypothalamic pituitary; ICU; Sepsis; Systemic inflammatory response syndrome

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; CYTOKINE; DEXAMETHASONE; ETOMIDATE; GLUCOCORTICOID; HYDROCORTISONE; METHYLPREDNISOLONE;

ADRENAL DISEASE; ADRENAL INSUFFICIENCY; ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR SYSTEM; CLINICAL FEATURE; CLINICAL TRIAL; CORTICOTROPIN RELEASE; CRITICAL ILLNESS; DIAGNOSTIC PROCEDURE; EXHAUSTION; FATALITY; FEVER; HORMONAL REGULATION; HORMONE ACTION; HORMONE METABOLISM; HORMONE RESISTANCE; HUMAN; HYDROCORTISONE RELEASE; HYPOTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; INCIDENCE; NONHUMAN; PAIN; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SEPSIS; STRESS;

EID: 0036434848     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.5.1784     Document Type: Article

References (121)

1. Jurney TH, Cockrell JL Jr, Lindberg JS, et al. Spectrum of serum cortisol response to ACTH in ICU patients: Correlation with degree of illness and mortality. Chest 1987; 92:292-295
2. Reincke M, Allolio B, Wurth G, et al. The hypothalamic-pituitary-adrenal axis in critical illness: Response to dexamethasone and corticotropin-releasing hormone. J Clin Endocrinol Metab 1993; 77:151-156
3. Hinshaw LB, Beller BK, Chang AC, et al. Corticosteroid/antibiotic treatment of adrenalectomized dogs challenged with lethal E. coli. Circ Shock 1985; 16:265-277
4. Darlington DN, Chew G, Ha T, et al. Corticosterone, but not glucose, treatment enables fasted adrenalectomized rats to survive moderate hemorrhage. Endocrinology 1990; 127:766-772
5. Ledingham IM, Watt I. Influence of sedation on mortality in critically ill multiple trauma patients [letter]. Lancet 1983; 1:1270
6. Addison T. Anaemia-disease of the supra-renal capsules. Lond Med Gaz 1849; 43:517-518
7. May ME, Vaughan ED, Carey RM. Adrenocortical insufficiency: Clinical aspects. In: Vaughan ED, Carey RM, eds. Adrenal Disorders. New York, NY: Thieme Medical, 1989; 171-189
8. Hollenberg SM, Weinberger C, Ong ES, et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985; 318:635-641
9. Yang J, DeFranco DB. Assessment of glucocorticoid receptor-heat shock protein 90 interactions in vivo during nucleocytoplasmic trafficking. Mol Endocrinol 1996; 10:3-13
10. Pilkis SJ, Granner DK. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol 1992; 54:885-909
11. Sakaue M, Hoffman BB. Glucocorticoids induce transcription and expression of the α1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J Clin Invest 1991; 88:385-389
12. Collins S, Caron MG, Lefkowitz RJ. β-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J Biol Chem 1988; 263:9067-9070
13. Orlowski J, Lingrel JB. Thyroid and glucocorticoid hormones regulate the expression of multiple Na, K-ATPase genes in cultured neonatal rat cardiac myocytes. J Biol Chem 1990; 265:3462-3470
14. Satoh S, Oishi K, Iwagaki A, et al. Dexamethasone impairs pulmonary defense against Pseudomonas aeruginosa through suppressing iNOS gene expression and peroxynitrite production in mice. Clin Exp Immunol Life 2001; 126:266-273
15. Matsumura M, Kakishita H, Suzuki M, et al. Dexamethasone suppresses iNOS gene expression by inhibiting NF-κB in vascular smooth muscle cells. Life Sci 2001; 69:1067-1077
16. Redington AE, Meng QH, Springall DR, et al. Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax 2001; 56:351-357
17. Fujii E, Yoshioka T, Ishida H, et al. Evaluation of iNOS-dependent and independent mechanisms of the microvascular permeability change induced by lipopolysaccharide. Br J Pharmacol 2000; 130:90-94
18. Munck A, Naray-Fejes-Toth A. Glucocorticoids and stress: Permissive and suppressive actions. Ann NY Acad Sci 1994; 746:115-130
19. Fahey JV, Guyre PM. Mechanisms of anti-inflammatory actions of glucocorticoids. Adv Inflamm Res 1981; 2:21-51
20. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: Molecular mechanisms. Trends Pharmacol Sci 1993; 14: 436-441
21. Barnes PJ, Karin M. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336:1066-1071
22. Auphan N, Didonato JA, Rosette C, et al. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis. Science 1995; 270:286-290
23. Barber AEI, Coyle SM, Fischer E, et al. Influence of hypercortosolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings. Surgery 1995; 118:406-410
24. van der Poll T, Barber AE, Coyle SM, et al. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia: A clinical research center study. J Clin Endocrinol Metab 1996; 81:3604-3606
25. Knudsen PJ, Dinarello CA, Strom TB. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol 1987; 139: 4129-4134
26. Szabo C, Thiemermann C, Wu CC, et al. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci U S A 1994; 91:271-275
27. Beishuizen A, Thijs LG, Vermes I. Patterns of corticosteroid-binding globulin and free cortisol index during septic shock and multitrauma. Intensive Care Med 2001; 27:1584-1591
28. Zaloga GP, Bhatt B, Marik PE. Critical illness and systemic inflammation. In: Becker K, Nylen E, eds. Practice and Principles of Endocrinology and Metabolism. Philadelphia, PA: Lippincott, Williams, and Wilkins, 2001; 2068-2076
29. Besedovsky HO, del Ray A. Immuno-neuro-endocrine interactions: Facts and hypotheses. Endocr Rev 1996; 17:64-102
30. Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action. Physiol Rev 1999; 79:1-71
31. Mastorakos G, Chrousos GP, Weber JS. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 1993; 77:1690-1694
32. Bateman A, Singh A, Kral T, et al. The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 1989; 10:92-112
33. Gaillard RC, Turnill D, Sappino P, et al. Tumor necrosis factor α inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology 1990; 127:101-106
34. Richards ML, Caplan RH, Wickus GG, et al. The rapid low-dose (1 microgram) cosyntropin test in the immediate postoperative period: Results in elderly subjects after major abdominal surgery. Surgery 1999; 125:431-440
35. Soni A, Pepper GM, Wyrwinski PM, et al. Adrenal insufficiency occurring during septic shock: Incidence, outcome, and relationship to peripheral cytokine levels. Am J Med 1995; 98:266-271
36. Schroeder S, Wichers M, Klingmuller D, et al. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: Altered response to corticotropin-releasing hormone. Crit Care Med 2001; 29:310-316
37. Catalano RD, Parameswaran V, Ramachandran J, et al. Mechanisms of adrenocortical depression during Escherichia coli shock. Arch Surg 1984; 119:145-150
38. Keri G, Parameswaran V, Trunkey DD, et al. Effects of septic shock plasma on adrenocortical cell function. Life Sci 1981; 28:1917-1923
39. Melby JC, Egdahl RH, Spink WW. Secretion and metabolism of cortisol after injection of endotoxin. J Lab Clin Med 1960; 56:50-62
40. Jaattela M, Ilvesmaki V, Voutilainen R, et al. Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology 1991; 128:623-629
41. Zhu Q, Solomon S. Isolation and mode of action of rabbit corticostatic (antiadrenocorticotropin) peptides. Endocrinology 1992; 130:1413-1423
42. Masera RG, Bateman A, Muscettola M, et al. Corticostatins/defensins inhibit in vitro NK activity and cytokine production by human peripheral blood mononuclear cells. Regul Pept 1996; 62:13-21
43. Tominaga T, Fukata J, Hayashi Y, et al. Distribution and characterization of immunoreactive corticostatin in the hypothalamic-pituitary-adrenal axis. Endocrinology 1992; 130:1593-1598
44. Natarajan R, Ploszay S, Horton R, et al. Tumor necrosis factor and interleukin-1 are potent inhibitors of angiotensin II induced aldosterone synthesis. Endocrinology 1989; 125:3084-3089
45. Jaattela M, Carpen O, Stenman UH, et al. Regulation of ACTH-induced steroidogenesis in human fetal adrenals by rTNF-α. Mol Cell Endocrinol 1990; 68:R31-R36
46. Pariante CM, Pearce BD, Pisell TL, et al. The proinflammatory cytokine, interleukin-1α, reduces glucocorticoid receptor translocation and function. Endocrinology 1999; 140:4359-4366
47. Melby JC, Spink WW. Comparative studies of adrenal cortisol function and cortisol metabolism in healthy adults and in patients with septic shock due to infection. J Clin Invest 1958; 37:1791-1798
48. McCallum RE, Stith RD. Endotoxin-induced inhibition of steroid binding by mouse liver cytosol. Circ Shock 1982; 9:357-367
49. Schuler JJ, Erve PR, Schumer W. Glucocorticoid effect on hepatic carbohydrates metabolism in the endotoxin-shocked monkey. Ann Surg 1976; 183:345-354
50. Streeten DHP. What test for hypothalamic-pituitary adrenocortical insufficiency? Lancet 1999; 354:179-180
51. Clark PM, Neylon I, Raggatt PR, et al. Defining the normal cortisol response to the short Synacthen test: Implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol 1998; 49:287-292
52. Streeten DHP, Anderson GH, Dalakos TG, et al. Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man. Endocr Rev 1984; 5: 371-394
53. Lamberts SW, Bruining HA, de Jong FH. Corticosteroid therapy in severe illness. N Engl J Med 1997; 337: 1285-1292
54. Naito Y, Fukata J, Tamai S, et al. Biphasic changes in hypothalamic-pituitary-adrenal function during the early recovery period after major abdominal surgery. J Clin Endocrinol Metab 1991; 73:111-117
55. Naito Y, Tamai S, Shingu K, et al. Responses of plasma adrenocorticotropic hormone, cortisol, and cytokines during and after upper abdominal surgery. Anesthesiology 1992; 77:426-431
56. Karayiannakis AJ, Makri GG, Mantzioka A, et al. Systemic stress response after laparoscopic or open cholecystectomy: A randomized trial. Br J Surg 1997; 84:467-471
57. Schricker T, Carli F, Schreiber M, et al. Propofol/sufentanil anesthesia suppresses the metabolic and endocrine response during, not after, lower abdominal surgery. Anesth Analg 2000; 90:450-455
58. Motamed S, Klubien K, Edwardes M, et al. Metabolic changes during recovery in normothermic vs hypothermic patients undergoing surgery and receiving general anesthesia and epidural local anesthetic agents. Anesthesiology 1998; 88:1211-1218
59. Plunkett JJ, Reeves JD, Ngo L, et al. Urine and plasma catecholamine and cortisol concentrations after myocardial revascularization: Modulation by continuous sedation. Multicenter Study of Perioperative Ischemia (McSPI) Research Group, and the Ischemia Research and Education Foundation (IREF). Anesthesiology 1997; 86:785-796
60. Vermes I, Beishuizen A, Hampsink RM, et al. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: Possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 1995; 80:1238-1242
61. Wade CE, Lindberg JS, Cockrell JL, et al. Upon-admission adrenal steroidogenesis is adapted to the degree of illness in intensive care unit patients. J Clin Endocrinol Metab 1988; 67:223-227
62. Rothwell PM, Lawler PG. Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 1995; 23:78-83
63. Chernow B, Rainey TR, Lake CR. Endogenous and exogenous catecholamines in critical care medicine. Crit Care Med 1982; 10:409-416
64. Hart BB, Stanford GG, Ziegler MG, et al. Catecholamines: Study of interspecies variation. Crit Care Med 1989; 17: 1203-1218
65. Zaloga GP, Marik P. Hypothalamic-pituitary-adrenal insufficiency. Crit Care Clin 2001; 17:25-42
66. Schein RMH, Sprung CL, Marcial E. Plasma cortisol levels in patients with septic shock. Crit Care Med 1990; 18:259-263
67. Drucker D, Shandling M. Variable adrenocortical function in acute medical illness. Crit Care Med 1985; 13:477-479
68. Chernow B, Alexander HR, Smallridge RC, et al. Hormonal responses to graded surgical stress. Arch Intern Med 1987; 147:1273-1278
69. Donald RA, Perry EG, Wittert GA, et al. The plasma ACTH, AVP, CRH, and catecholamine responses to conventional and laparoscopic cholecystectomy. Clin Endocrinol 1993; 38:609-615
70. Rivers EP, Gaspari M, Abi Saad G, et al. Adrenal insufficiency in high-risk surgical ICU patients. Chest 2001; 119:889-896
71. Annane D, Sebille V, Troche G, et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283:1038-1045
72. Annane D, Bellissant E. Prognostic value of cortisol response in septic shock. JAMA 2000; 284:308-309
73. Streeten DH, Anderson GH Jr, Bonaventura MM. The potential for serious consequences from misinterpreting normal responses to the rapid adrenocorticotropin test. J Clin Endocrinol Metab 1996; 81:285-290
74. Beishuizen A, Vermes I, Hylkema BS, et al. Relative eosinophilia and functional adrenal insufficiency in critically ill patients [letter]. Lancet 1999; 353:1675-1676
75. Drucker D, McLaughlin J. Adrenocortical dysfunction in acute medical illness. Crit Care Med 1986; 14:789-791
76. Sibbald WJ, Short A, Cohen MP, et al. Variations in adrenocortical responsiveness during severe bacterial infections: unrecognized adrenocortical insufficiency in severe bacterial infections. Ann Surg 1977; 186:29-33
77. Hampson N, Norkool D. Carbon monoxide poisoning in children riding in the back of pickup trucks. JAMA 1992; 267:538-540
78. Dennhardt R, Gramm HJ, Meinhold K, et al. Patterns of endocrine secretion during sepsis. Prog Clin Biol Res 1989; 308:751-756
79. McKee JI, Finlay WE. Cortisol replacement in severely stressed patients [letter]. Lancet 1983; 1:484
80. Marik PE, Zaloga GP. Adrenal insufficiency during septic shock. Crit Care Med (in press)
81. Borst GC, Michenfelder HJ, O'Brian JT. Discordant cortisol response to exogenous ACTH and insulin-induced hypoglycemia in patients with pituitary disease. N Engl J Med 1982; 306:1462-1464
82. Lindholm J, Kehlet H. Re-evaluation of the clinical value of the 30 minute ACTH test in assessing he hypothalamic-pituitary-adrenocortical function. Clin Endocrinol 1987; 26:53-59
83. Broide J, Soferman R, Kivity S, et al. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab 1995; 80:1243-1246
84. Mayenknecht J, Diederich S, Bahr V, et al. Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endocrinol Metab 1998; 83: 1558-1562
85. Rasmuson S, Olsson T, Hagg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 1996; 44:151-156
86. Tordjman K, Jaffe A, Grazas N, et al. The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases. J Clin Endocrinol Metab 1995; 80:1301-1305
87. Abdu TA, Elhadd TA, Neary R, et al. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 1999; 84:838-843
88. Marik PE, Kiminyo K, Zaloga GP. Adrenal insufficiency in critically ill HIV infected patients. Crit Care Med 2002; 30:1267-1273
89. Parker LN, Levin ER, Lifrak ET. Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 1985; 60:947-952
90. Briegel J, Scheelling G, Haller M, et al. A comparison of the adrenocortical response during septic shock and after complete recovery. Intensive Care Med 1996; 22:894-899
91. Barquist E, Kirton O. Adrenal insufficiency in the surgical intensive care unit patient. J Trauma 1997; 42:27-31
92. Rydvall A, Brandstrom AK, Banga R, et al. Plasma cortisol is often decreased in patients in an intensive care unit. Intensive Care Med 2000; 26:545-551
93. Moran JL, Chapman MJ, O'Fathartaigh MS, et al. Hypocortisolaemia and adrenocortical responsiveness at onset of septic shock. Intensive Care Med 1994; 20:489-495
94. Oelkers W. Adrenal insufficiency. N Engl J Med 1996; 335:1206-1212
95. Pulakhandam U, Dincsoy HP. Cytomegaloviral adrenalitis and adrenal insufficiency in AIDS. Am J Clin Pathol 1990; 93:651-656
96. Glasgow BJ, Steinsapir KD, Anders K, et al. Adrenal pathology in the acquired immune deficiency syndrome. Am J Clin Pathol 1985; 84:594-597
97. Welch K, Finkbeiner W, Alpers CE, et al. Autopsy findings in the acquired immune deficiency syndrome. JAMA 1984; 252:1152-1159
98. Grinspoon SK, Bilezikian JP. HIV disease and the endocrine system. N Engl J Med 1992; 327:1360-1365
99. Aron DC. Endocrine complications of the acquired immunodeficiency syndrome. Arch Intern Med 1989; 149:330-333
100. Sonino N. The use of ketoconazole as an inhibitor of steroid production. N Engl J Med 1987; 317:812-818
101. Smith GH. Treatment of infections in the patient with acquired immunodeficiency syndrome. Arch Intern Med 1994; 154:949-973
102. Hofbauer LC, Heufelder AE. Endocrine implications of human immunodeficiency virus infection. Medicine 1996; 75:262-278
103. Schlaghecke R, Kornely E, Santen RT, et al. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med 1992; 326:226-230
104. Kannisto S, Korpi M, Remes K, et al. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metab 2000; 85:652-657
105. Henzen C, Suter A, Lerch E, et al. Suppression and recovery of adrenal response after short-term high-dose glucocorticoid treatment. Lancet 2000; 355:542-545
106. Jasani MK, Boyle JA, Greig WR, et al. Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: Observations on patients given oral corticosteroids for rheumatoid arthritis. Q J Med 1967; 36:261-276
107. Krasner AS. Glucocorticoid-induced adrenal insufficiency. JAMA 1999; 282:671-676
108. Zaloga GP. Sepsis-induced adrenal deficiency syndrome. Crit Care Med 2001; 29:688-690
109. Koo DJ, Jackman D, Chaundry IH, et al. Adrenal insufficiency during the late stage of polymicrobial sepsis. Crit Care Med 2001; 29:618-622
110. Annane D, Bellissant E, Bollaert PE. The hypothalamic-pituitary axis in septic shock. Br J Intensive Care 1996; 6:260-268
111. Ali M, Allen HR, Vedeckis WV, et al. Depletion of rat liver glucocorticoid receptor hormone-binding and its mRNA in sepsis. Life Sci 1991; 48:603-611
112. Molijn GJ, Koper JW, van Uffelen CJ, et al. Temperature-induced down-regulation of the glucocorticoid receptor in peripheral blood mononuclear leukocytes in patients with sepsis and septic shock. Clin Endocrinol 1995; 43:197-203
113. Norbiato G, Bevilacqua M, Vago T, et al. Cortisol resistance in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992; 74:608-613
114. Bollaert PE, Charpentier C, Levy B, et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26:645-650
115. Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732
116. Annane D. Effects of the combination of hydrocortisone-fludro-cortisone on mortality in septic shock [abstract]. Crit Care Med 2000; 28(suppl):A46
117. Oppert M, Reinicke A, Graf KJ, et al. Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock. Intensive Care Med 2000; 26:1747-1755
118. The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987; 317:659-665
119. Bone RC, Fisher CJ, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 317:653-658
120. Schelling G, Stoll C, Kapfhammer HP, et al. The effect of stress doses of hydrocortisone during septic shock on post-traumatic stress disorder and health-related quality of life in survivors. Crit Care Med 1999; 27:2678-2683
121. Salem M, Trainsh RE, Bromberg J, et al. Perioperative glucocorticoid coverage: A reassessment 42 years after emergence of a problem. Ann Surg 1994; 219:416-425